April 1, 2022

Dr. Dixon interviewed by USA Today and WISH-TV

A CDC study with contributions from Regenstrief shows that booster shots are more effective at preventing moderate COVID-19 cases than a single Johnson and Johnson dose. Study author and Regenstrief Director of Public Health Informatics Brian Dixon, PhD, MPA, explained the implications of these findings.

A CDC study with contributions from Regenstrief shows that booster shots are more effective at preventing moderate COVID-19 cases than a single Johnson and Johnson dose. Study author and Regenstrief Director of Public Health Informatics Brian

READ THE USA TODAY STORY READ THE WISH-TV STORY
The Latest
Renowned delirium researcher and clinician named Regenstrief interim center director
News

Renowned delirium researcher and clinician named Regenstrief interim center director

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation
News

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults
News

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release
News

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation
News

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation

Regenstrief to host 2025 LOINC® conference in Montréal, Canada, Oct. 7-10
News

Regenstrief to host 2025 LOINC® conference in Montréal, Canada, Oct. 7-10